HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Azathioprine and diffuse alveolar haemorrhage: the pharmacogenetics of thiopurine methyltransferase.

Abstract
Current guidelines support the use of corticosteroids and azathioprine as one possible treatment strategy for idiopathic pulmonary fibrosis (IPF). However, some patients with genetic polymorphisms of thiopurine methyltransferase (TPMT) are at risk of severe azathioprine myelotoxicity. The current authors present the case of an 85-yr-old Caucasian male with IPF who developed diffuse alveolar haemorrhage as a complication of azathioprine-induced myelosuppression. Leukocyte genetic TPMT testing revealed that the patient had homozygous polymorphisms associated with the absence of TPMT activity and severe azathioprine-induced myelotoxicity. Thiopurine methyltransferase deficiency should be considered in patients who develop leukopenia early in treatment with azathiopurine, or who present with severe marrow suppression at usual doses. For centres with equipped laboratories, a dosing suggestion is provided based on thiopurine methyltransferase testing. Even with screening strategies, frequent monitoring of complete blood count and liver biochemistry should remain the mainstay of surveillance for azathioprine toxicity.
AuthorsD Perri, D E C Cole, O Friedman, E Piliotis, S Mintz, N K J Adhikari
JournalThe European respiratory journal (Eur Respir J) Vol. 30 Issue 5 Pg. 1014-7 (Nov 2007) ISSN: 0903-1936 [Print] England
PMID17978158 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Immunosuppressive Agents
  • Methyltransferases
  • thiopurine methyltransferase
  • Azathioprine
Topics
  • Azathioprine (adverse effects)
  • Female
  • Hemorrhage (chemically induced, enzymology)
  • Humans
  • Immunosuppressive Agents (adverse effects)
  • Lung Diseases (chemically induced, enzymology)
  • Male
  • Methyltransferases (deficiency, genetics)
  • Pharmacogenetics
  • Polymorphism, Genetic
  • Pulmonary Fibrosis (drug therapy, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: